Abbott Laboratories (ABT)
Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
Recs
00100
(96.44)
Submitted: 4/13/2009 7:55:50 PM :
Start Price:
$43.79
ABT Score:
-8.09
3/16/09 Pitch: Upthumb. Earnings 4/15/09. Money making machine. Core position. Recently increased dividend. Consistent positive standout in Barron's and Wall Street commentary. Could be posed for strong growth in 2009 and 2010.
Past Trades:
12/31/08 Upthumb. 1/21/2009 Earnings Day and day after Inauguration Day for President Obama. Believe that we will see large runup across the board from Dec 30 'til that day. Added Pitch on 01/10/09: Earnings 1/21/09, 9:00 AM Still think this is a good industry to be in during the recession. Closed 1/21/09 @ $52.32 for +6.84 points.
10/10/08 Upthumb. Earnings 10/15/08, 9:00 AM Good product pipeline, good industry to be in during recession. Closed 10/17/2008 @ $55.61 for +7.48 points.
Recs
1mikerb
(83.36)
Submitted: 3/24/2008 11:22:55 PM :
Start Price:
$52.45
ABT Score:
+18.08
The past 5 days ABT has outperformed the S&P 500 +7.87 to +4.79. The past month, it is +1.62 t0 -0.24.
Abbott Laboratories is one of the best Biopharmaceuticals
companies in the world.
Recs
3pokerchamp6
(21.76)
Submitted: 5/28/2008 12:15:14 AM :
Start Price:
$52.32
ABT Score:
+20.91
slow but will move up
Recs
881500
(84.86)
Submitted: 7/31/2008 7:50:09 AM :
Start Price:
$54.34
ABT Score:
+9.92
i got it, i reccomend it, you buy it, the price goes up, I love this site.
zacks buy rank 3
target 65.
Recs
A00971591
(24.29)
Submitted: 9/10/2009 6:28:00 PM :
Start Price:
$46.52
ABT Score:
+10.37
Good strong company that is diversified well, the four segments of this company seem to be very promising. Let's just hope Obama care doesn't make this company tank
Recs
AGraziano
(58.23)
Submitted: 3/17/2007 7:47:49 AM :
Start Price:
$49.09
ABT Score:
+26.27
Very well diversified blue chip.
Recs
agstocknut
(26.55)
Submitted: 8/19/2009 9:52:05 AM :
Start Price:
$43.83
ABT Score:
+11.04
Earnings just keep growing!
Recs
Aiden1976
(97.54)
Submitted: 3/20/2008 2:03:35 AM :
Start Price:
$51.83
ABT Score:
+16.17
By joint venture along side with the biggest pharmaceutical of Japan, Takeda. TAP product of the Prevacid and Lupron will benefit both company with many years to come globely. Not to mention that they have few new products are under review by the FDA.
Recs
alfred13
(72.55)
Submitted: 4/9/2009 6:20:11 PM :
Start Price:
$43.13
ABT Score:
-6.38
I have watched this one make money from the sidelines for several years...just decided to get off the sidelines and own it. Performance has been consistent over the years, and very good.
Recs
Alzo10
(91.14)
Submitted: 7/2/2009 7:48:02 AM :
Start Price:
$45.53
ABT Score:
-3.30
Cash flowing very nicely, and a company that has consistently beaten estimates while paying a nice dividend. This is an $80+ stock.
Recs
amteague777
(97.46)
Submitted: 4/26/2007 8:25:34 PM :
Start Price:
$52.71
ABT Score:
+24.25
Dividends increased for the 34th straight year. Net income fell by nearly half for 2006, but that money went into r&d. Asset to liabilty ratio doesn't provide enough cushion. Consistent increase in net income 2003-2005. From 2000 to 2006 stock price went virtually no where. 2000 to 2005 return on investment was good but 2006 took a beating with 12.1%.
Recs
aracer
(99.65)
Submitted: 10/22/2008 4:55:44 PM :
Start Price:
$52.42
ABT Score:
-22.50
Good safe pharma at a good price.
Recs
Recs
Arjunmarkanda
(21.52)
Submitted: 8/3/2007 5:06:01 AM :
Start Price:
$47.93
ABT Score:
+33.93
good fundamentals
Recs
azaw
(79.71)
Submitted: 6/5/2008 4:46:30 PM :
Start Price:
$53.03
ABT Score:
+20.34
Seems to grow steadily.
Recs
barnetadb
(72.72)
Submitted: 5/7/2007 12:24:14 PM :
Start Price:
$54.87
ABT Score:
+21.20
The star of my portfolio sofar and getting stronger by the week. Some potential limits on the upside but so far so good.
Recs
bdz
(85.49)
Submitted: 4/19/2007 5:13:11 PM :
Start Price:
$53.95
ABT Score:
-21.42
heavy competition
Recs
beanner22
(< 20)
Submitted: 3/20/2008 10:48:46 PM :
Start Price:
$52.88
ABT Score:
-16.25
Too many lawsuits happening with prescription drugs. Layoffs are happening often.
Recs
bheald6
(40.00)
Submitted: 4/20/2007 10:29:44 AM :
Start Price:
$53.84
ABT Score:
+21.60
Diversifia yourself
Recs
bigbonesmagoo
(94.40)
Submitted: 4/8/2009 9:30:01 PM :
Start Price:
$42.19
ABT Score:
-7.65
Recent downgrade was a disgrace....stents are booming (perhaps best of class), smart management...Humira is a great product and don't see the slowing that prompted the downgrade....too cheap--should be trading at $55 minimum.
This is a conservative--nasty company--Miles White is a nasty SOB--just how I like them running my companies...
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 212 1 2 3 4 5 6 7 8 9 10 Next »